CME/CE Podcast: Candid Conversations about Menopause Treatment Barriers

The NACE Clinical Highlights Show

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:
https://www.mycme.com/courses/candid-conversations-about-menopause-treatment-barriers-9387
Summary
Join Dr. Genevieve Neil-Perry as she moderates a dynamic panel discussion on the obstacles hindering access to quality menopause treatment. Dr. Gregg Sherman (primary care) and Dr. Nanette Santoro (OB/GYN) bring their clinical perspectives, while a patient joins and shares their firsthand experiences.
This episode explores the unique challenges faced by patients and providers within the menopause care landscape. The panel delves into potential solutions, aiming to empower listeners with knowledge and strategies to overcome these barriers for improved menopause care.
Learning Objective

• Identify patient and clinician barriers to management of menopausal symptoms

This activity is accredited for CME/CE Credit
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which does not include hours of pharmacology ).
For additional information about the accreditation of this program, contact NACE at [e-mail].
Summary of Individual Disclosures
Angela Golden has disclosed the following financial relationships:

• Consultant: Novo Nordisk (obesity), Lilly (obesity), Acella (thyroid), Currax (obesity), Boehringer Ingelheim (obesity), WW (obesity), Gelesis (obesity - relationship has ended)
• Speaker: Novo Nordisk (obesity), Lilly (obesity), Acella (thyroid), Currax (obesity)
• Receipt of Royalty: Springer (obesity - relationship has ended), Amazon (fiction)

Guest Patient has no relevant financial relationships to disclose.
Bernadette Makar has no relevant financial relationships to disclose.
Gregg Sherman has no relevant financial relationships to disclose.
Genevieve Neal-Perry has disclosed the following financial relationships:

• Scientific Advisory Board: Astellas (women’s health), Natera (women’s health)
• Review Panel: SRI (professional organization)

Nanette Santoro has disclosed the following financial relationships:

• Consultant: Astellas Pharma, MenoGeniX, Ansh Labs
• All disclosures are related to women's health.

All of the relevant financial relationships listed for these individuals have been mitigated. Faculty, planners, guest patient(s) (if applicable), and moderators for this educational activity not listed in the Summary of Individual Disclosures above have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Disclosure of Commercial Support
This educational activity is

Please visit http://naceonline.com to engage in more live and on demand CME/CE content.